Korean J Gastroenterol.  2021 Jul;78(1):27-30. 10.4166/kjg.2021.411.

Gender Difference in Gallbladder Cancer: Focusing on the Clinical Characteristics, Treatment, and Prognosis of Korean Patients

• Kim EJ

• KMID: 2518747
• DOI: http://doi.org/10.4166/kjg.2021.411

Abstract

Gallbladder cancer (GBC) is a relatively uncommon malignancy of the gastrointestinal tract, but it has a poor prognosis. Most cases of GBC are initially diagnosed in advanced stage and the efficacy of currently available treatments have been disappointing. Sex and gender medicine investigates the clinical impact of sex and gender difference on diseases and it may provide a good starting point for the personalized medicine. In this article, sex and gender differences in GBC are explained based on an overview of epidemiology and risk factors focusing on recent researches.

Keyword

Gallbladder cancer; Gender

Reference

1. Wang SJ, Lemieux A, Kalpathy-Cramer J, et al. 2011; Nomogram for predicting the benefit of adjuvant chemoradiotherapy for resected gallbladder cancer. J Clin Oncol. 29:4627–4632. DOI: 10.1200/JCO.2010.33.8020. PMID: 22067404. PMCID: PMC3236647.

2. Goetze TO. 2015; Gallbladder carcinoma: prognostic factors and therapeutic options. World J Gastroenterol. 21:12211–12217. DOI: 10.3748/wjg.v21.i43.12211. PMID: 26604631. PMCID: PMC4649107.

3. Stinton LM, Shaffer EA. 2012; Epidemiology of gallbladder disease: cholelithiasis and cancer. Gut Liver. 6:172–187. DOI: 10.5009/gnl.2012.6.2.172. PMID: 22570746. PMCID: PMC3343155.

4. Sheth S, Bedford A, Chopra S. 2000; Primary gallbladder cancer: recognition of risk factors and the role of prophylactic cholecystectomy. Am J Gastroenterol. 95:1402–1410. DOI: 10.1111/j.1572-0241.2000.02070.x. PMID: 10894571.

5. Saranga Bharathi R, Singh R, Gupta R, et al. 2015; Female sex hormone receptors in gallbladder cancer. J Gastrointest Cancer. 46:143–148. DOI: 10.1007/s12029-015-9698-z. PMID: 25772307.

6. Gupta P, Agarwal A, Gupta V, Singh PK, Pantola C, Amit S. 2012; Expression and clinicopathological significance of estrogen and progesterone receptors in gallbladder cancer. Gastrointest Cancer Res. 5:41–47.

7. Rahman R, Simoes EJ, Schmaltz C, Jackson CS, Ibdah JA. 2017; Trend analysis and survival of primary gallbladder cancer in the United States: a 1973-2009 population-based study. Cancer Med. 6:874–880. DOI: 10.1002/cam4.1044. PMID: 28317286. PMCID: PMC5387125.

8. Henley SJ, Weir HK, Jim MA, Watson M, Richardson LC. 2015; Gallbladder cancer incidence and mortality, United States 1999-2011. Cancer Epidemiol Biomarkers Prev. 24:1319–1326. DOI: 10.1158/1055-9965.EPI-15-0199. PMID: 26070529.

9. Wi Y, Woo H, Won YJ, Jang JY, Shin A. 2018; Trends in gallbladder cancer incidence and survival in Korea. Cancer Res Treat. 50:1444–1451. DOI: 10.4143/crt.2017.279. PMID: 29370591. PMCID: PMC6192934.

10. Chianale J, del Pino G, Nervi F. 1990; Increasing gall-bladder cancer mortality rate during the last decade in Chile, a high-risk area. Int J Cancer. 46:1131–1133. DOI: 10.1002/ijc.2910460630. PMID: 2249900.

11. Mathur AV. 2015; Need for prophylactic cholecystectomy in silent gall stones in North India. Indian J Surg Oncol. 6:251–255. DOI: 10.1007/s13193-015-0418-8. PMID: 27217672. PMCID: PMC4856674.

12. Muszynska C, Nilsson J, Lundgren L, et al. 2020; A risk score model to predict incidental gallbladder cancer in patients scheduled for cholecystectomy. Am J Surg. 220:741–744. DOI: 10.1016/j.amjsurg.2020.01.039. PMID: 32037044.

13. Lee KB. 2018; Histologic and molecular pathogenesis of gallbladder cancer. Korean J Pancreas Biliary Tract. 23:1–6. DOI: 10.15279/kpba.2018.23.1.1.

14. Bray F, Ferlay J, Soerjomataram I, Siegel RL, Torre LA, Jemal A. 2018; Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 68:394–424. DOI: 10.3322/caac.21492. PMID: 30207593.

15. Torre LA, Siegel RL, Islami F, Bray F, Jemal A. 2018; Worldwide burden of and trends in mortality from gallbladder and other biliary tract cancers. Clin Gastroenterol Hepatol. 16:427–437. DOI: 10.1016/j.cgh.2017.08.017. PMID: 28826679.